KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Payables (2016 - 2025)

Historic Payables for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $4.3 billion.

  • Bristol Myers Squibb's Payables rose 2360.91% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year increase of 2360.91%. This contributed to the annual value of $3.6 billion for FY2024, which is 1052.47% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Payables stood at $4.3 billion for Q3 2025, which was up 2360.91% from $5.4 billion recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Payables high stood at $5.4 billion for Q2 2025, and its period low was $2.6 billion during Q3 2022.
  • For the 5-year period, Bristol Myers Squibb's Payables averaged around $3.4 billion, with its median value being $3.2 billion (2023).
  • As far as peak fluctuations go, Bristol Myers Squibb's Payables plummeted by 2014.41% in 2022, and later skyrocketed by 4468.14% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Payables stood at $2.9 billion in 2021, then grew by 3.09% to $3.0 billion in 2022, then increased by 7.2% to $3.3 billion in 2023, then increased by 10.52% to $3.6 billion in 2024, then grew by 19.04% to $4.3 billion in 2025.
  • Its Payables was $4.3 billion in Q3 2025, compared to $5.4 billion in Q2 2025 and $4.0 billion in Q1 2025.